0069-4004 : Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution


NDC0069-4004
Labeler: Pfizer Laboratories Div Pfizer Inc
Product Type: Human Prescription Drug
Drug Name:  Doxorubicin Hydrochloride
Dosage Form: Intravenous Injection, Solution
Application #: NDA050629
Rev. Date: 


NDC Package Codes:

  • 0069-4004-05: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (0069‑4004‑05) > 5 ML IN 1 VIAL, SINGLE‑DOSE

Active Ingredients:

  • Doxorubicin Hydrochloride

Dosage Strength:

  • 2 mg/mL

Pharmaceutical Classes:

  • Anthracycline Topoisomerase Inhibitor [EPC]
  • Anthracyclines [Chemical/Ingredient]
  • Topoisomerase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0069-3030 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-3031 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-3032 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-3033 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-3034 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-4015 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-4026 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-4030 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-4031 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-4032 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-4033 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-4034 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-4037 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-0170 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Pfizer Laboratories Div Pfizer Inc.
  • 0069-0171 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Pfizer Laboratories Div Pfizer Inc.
  • 0409-0124 Doxorubicin Hydrochloride 2 mg/ml Intra-arterial; Intravenous; Intravesical Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
  • 0703-5040 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
  • 0703-5043 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
  • 0703-5046 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
  • 16714-742 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injectable, Liposomal by Northstar Rxllc
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0069-4004 QR Code

< Prev: 0069-3859Next: 0069-4015 >




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 21 July 2015.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA